Company intelligence / Profile preview

Nutrition21

Harrison, New York, United Statesnutrition21.com ↗

Ownership: Private
Development stage: Commercial

Overview

Nutrition21 develops clinically substantiated nutritional ingredients that are found in over 250 brands. Their products have been validated through over 80 research studies.

Therapeutic areas: Metabolic DisordersOtherPsychiatryDermatologyNeurology
Modalities: Nutritional ingredientsdietary supplements
Industry: Food & Nutrition

Drug pipeline

1 asset

LinearDNA COVID-19 vaccine

Pre-clinical

Indications: COVID-19

Partnerships

Previously had distribution agreement with Glanbia Nutritionals (ended December 21, 2017)

Beyond the preview

Go deeper on Nutrition21.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nutrition21.

Explore the full profile